Targeting metabolic activity in high-risk neuroblastoma through Monocarboxylate Transporter 1 (MCT1) inhibition.
Khan A, Valli E, Lam H, Scott DA, Murray J, Hanssen KM, Eden G, Gamble LD, Pandher R, Flemming CL, Allan S, Osterman AL, Haber M, Norris MD, Fletcher JI, Yu DMT.
Khan A, et al. Among authors: norris md.
Oncogene. 2020 Apr;39(17):3555-3570. doi: 10.1038/s41388-020-1235-2. Epub 2020 Mar 2.
Oncogene. 2020.
PMID: 32123312
Free PMC article.